We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Oversight Of Clinical Trials: Changes Loom

Law360 (November 15, 2007, 12:00 AM EST) -- On Sept. 28, 2007, the Office of the Inspector General for the Department of Health and Human Services (OIG) released a report entitled "The Food and Drug Administration’s Oversight of Clinical Trials" (the Report).

The OIG issued the Report pursuant to a congressional request to review oversight of clinical trials by the U.S. Food and Drug Administration (FDA) after a series of news articles detailed vulnerabilities in enforcement and monitoring of clinical trials in humans (For example, see David Evans et al., Drug Industry Human Testing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.